ArticleAmerican journal of human genetics1995
Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues.
Article in American journal of human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The Ischemic Stroke Genetics Study (ISGS) Protocol.BMC neurology · 2003Trial
- Facing Our History-Building an Equitable Future.American journal of human genetics · 2023Review
- The wide variation of definitions of genetic testing in international recommendations, guidelines and reports.Journal of community genetics · 2012Article
- Bio-Repository of DNA in stroke (BRAINS): a study protocol.BMC medical genetics · 2011Article
- Medical genetics: 3. An approach to the adult with a genetic disorder.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2002Article
- Mapping public policy on genetics.Gene therapy · 2002Article
- The Siblings With Ischemic Stroke Study (SWISS) protocol.BMC medical genetics · 2002Article
- Attitudes of physicians regarding receiving and storing patients' genetic testing results for cancer susceptibility.Journal of community health · 2000Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?
Indexed as
Identifiers
7825594PMC1801295What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.